AmerisourceBergen Technology Group on Thursday launched FastPak Elite, a tool that "reinvents the pouch packager to meet the demands of high-volume pharmacy operations, by putting medications in convenient multidose packaging," the company stated.
Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.
Lake Consumer Products, a subsidiary of Wisconsin Pharmacal Co., on Thursday acquired the exclusive North American rights to an over-the-counter product that addresses many of the key symptoms associated with premenstrual syndrome.
Ateb on Thursday announced it has reached an agreement to license Walgreens' entire portfolio of prescription alignment patents in an effort to continue to improve overall health care, demonstrate the value of medication synchronization and increase patient adherence rates.
Overall, the intimacy health category generated more than $870 million in sales, trending up in the low single-digits. Sales of condoms, the largest piece of the business, totaled $380.7 million across total U.S. multi-outlets for the 52 weeks ended April 20, and was down slightly by 1.8%. The growth is coming out of the personal lubricant ($213.4 million, up 2.9%) and emergency contraceptive ($253.2 million, up 12.3%) sectors.
Finnish beauty brand Lumene has kicked off 2014 with a bang with revamped packaging and a broadened product portfolio. The evolution continues as the company further extends its Bright Now line into anti-aging.
Anheuser-Busch InBev’s craft label Goose Island introduced several new brews. Madame Rose, part of a barrel-aged line that includes Halia, Gillian, Sofie, Juliet and Lolita, is a Belgian-style sour ale that is aged in cabernet barrels with wild yeast and fresh tart Michigan cherries.
The same weather factors that are boosting allergy sales as the allergy season is extended may be having a substantial impact on the sales of anti-itch ointments, up 10% to $528.2 million across U.S. multi-outlets for the 52 weeks ended April 20, according to IRI, and insect bite treatments, which totaled $13.6 million and were up 19.4% over the same period.